The report provides a detailed analysis essential for establishing a Lisdexamfetamine production plant. It encompasses all critical aspects necessary for Lisdexamfetamine production, including the cost of Lisdexamfetamine production, Lisdexamfetamine plant cost, Lisdexamfetamine production costs, and the overall Lisdexamfetamine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Lisdexamfetamine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Lisdexamfetamine is a prescription medication mainly used in the treatment of attention-deficit hyperactivity disorder (ADHD) and binge eating disorder. It is primarily utilised as a central nervous system stimulant that helps improve focus, attention, and impulse control in individuals with ADHD.
It also finds its application as a medication prescribed to reduce the frequency of binge eating episodes in adults. Moreover, Lisdexamfetamine is also used in clinical studies aimed at developing better therapies for conditions involving cognitive and behavioural disorders. It also finds additional use in medical research related to prodrug design, as it is converted in the body to dextroamphetamine, which is the active stimulant. Its long-lasting effect and controlled release properties make it suitable for once-daily dosing.
The demand for Lisdexamfetamine is primarily driven by its widespread use as a prescription drug for the treatment of ADHD and binge eating disorder, which strongly supports its market growth. Its application as a medication in improving focus, attention, and impulse control makes it a highly sought-after commodity among the pharmaceutical and healthcare industries. Moreover, the increasing prevalence of ADHD among children and adults, along with rising awareness about mental health treatment, further enhances its demand in the medical and healthcare industries.
Advancements in drug formulation, improved patient compliance, and growing adoption of long-acting stimulant medications also significantly contribute to market expansion. Furthermore, several factors, such as the availability of raw materials, production cost, strict regulatory standards, and ongoing pharmaceutical research, play an important role in influencing industrial Lisdexamfetamine procurement globally.
Raw Material for Lisdexamfetamine Production
According to the Lisdexamfetamine production plant project report, the major raw materials for Lisdexamfetamine production include BOC-protected L-lysine ammonium salt and Amphetamine (dextro, levo, or racemic).
Production Process of Lisdexamfetamine
The extensive Lisdexamfetamine production cost report consists of the following industrial production process:
- Production via Chemical synthesis: The production process of Lisdexamfetamine dimesylate begins with the reaction of a protected L-Lysine ammonium salt, such as BOC-L-Lys(BOC)—O—Et3NH+, in an organic solvent with an amphetamine compound. The amphetamine compound can be dextroamphetamine, levoamphetamine, or a racemic mixture. The reaction is carried out in an aqueous base using a coupling agent like DMTMM (4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride). The mixture forms two layers, which creates a biphasic system that is gently heated to around 30–50°C to promote the coupling of the amphetamine with the protected lysine carboxylic acid. The coupling results in the formation of the intermediate BOC-L-Lys(BOC)-N-amphetamine amide, which is further treated with methanesulfonic acid (MsOH) in a solvent mixture of isopropanol and isopropyl acetate. This reaction removes the protective groups and converts the compound into its mesylate salt form. Finally, the resulting product is subjected to crystallisation to obtain pure Lisdexamfetamine dimesylate as the final product.
Lisdexamfetamine is a prodrug psychostimulant that appears as a white to off-white crystalline powder. It is odourless and has a slightly bitter taste. The compound is freely soluble in water and sparingly soluble in methanol and ethanol. Its molecular formula is C15H25N3O, and its molar mass is 263.38 g/mol. The density of the compound is about 1.2 g/cm³. It has a melting point in the range of 176–178 degree Celsius and decomposes upon further heating. Lisdexamfetamine is chemically stable under normal storage conditions but may degrade when exposed to moisture or excessive heat. It is classified as a central nervous system stimulant and can cause adverse effects if misused, including increased heart rate, insomnia, and dependency. It acts as a prodrug of dextroamphetamine after enzymatic hydrolysis in the body. The compound is hygroscopic and should be stored in a tightly sealed container, away from light and humidity.
